Tag Archives: AMGN

Best Biotech Stocks To Own For 2017

Carl Icahn is getting more interested in biotech, notably Bristol-Myers Squibb (NYSE:BMY). For starters, Icahn has a stake in BMY, although it’s unclear how much. And now he has brought on a biotech expert to help run his fund. Icahn hired Harvard geneticist Richard Mulligan as a portfolio manager. Mulligan has worked with Icahn in […]

Top 10 Biotech Stocks For 2017

Raymond James analyst Christopher Raymond and team sayAbbVie (ABBV) is “not your father’s biotech company” as they initiate coverage with an Outperform rating: Kevin Hagen for The Wall Street Journal Initiating coverage of ABBV shares with an Outperform rating and an $82 price target as we think uncertainty over Humira’s intellectual property (IP) creates an […]

Top 5 Biotech Stocks For 2017

Sometimes you just have to pay respects to a great company and its leadership. A track record of excellent returns on invested capital, a great balance sheet, and stable earnings created through consistent customer service. Laudable indeed are the results of these high performers who bring service and value to society! In this article we’re […]

Regeneron: Whiplash!

It hasn’t been an easy time for investors inRegeneron Pharmaceuticals (REGN) recently…and today’s price action is likely to reinforce the sense of whiplash they must be feeling. Agence France-Presse/Getty Images What do I mean? Regeneron’s dropped 14% during the last three months, the result of a patent suit with Amgen(AMGN) over its anti-cholesterol drug Praluent, […]

Top 10 Biotech Stocks To Watch Right Now

Today, our Under the Radar Moversnewsletter suggested small cap clinical-stage biotechnology stockPfenex (NYSEMKT: PFNX) as a buy: With just a quick glance at Pfenex, it doesn’t look like much. Take a closer look though. There’s a method to all the volatile madness we’ve seen since the middle of the year. This back-and-forth indicates the bulls […]